Transforming Oncology Clinical Development through Precision AI
Smarter Trials | Quicker Readouts | Lower Cost
WHO WE ARE
We are a Precision AI company transforming oncology and hematology drug development. Built by oncology experts and powered by advanced AI, our platform streamlines clinical trial processes, delivers data-driven insights, and supports smarter decisions so that life-saving therapies can reach patients faster.
Our focus is narrow by design—cancer is complex, and generic AI doesn’t work here. We integrate scientific expertise with intelligent automation to meet the unique demands of modern cancer trials. With every partnership, we aim to raise the standard of precision in oncology drug development.
Expert Founders
Swami Murugappan MD PhD
Deva Senapathy BTech MBA
Deva Senapathy BTech MBA
Chief Medical Officer
A physician-scientist with over 15 years of experience in oncology drug development, leading multiple successful global regulatory approvals. Previously held leadership roles at Amgen, Kite Pharma / Gilead Sciences. Passionate about accelerating innovation in oncology through technology-driven approaches.
Deva Senapathy BTech MBA
Deva Senapathy BTech MBA
Deva Senapathy BTech MBA
Chief Technology Officer
A technology leader with deep expertise in enterprise software architecture and AI-driven platforms, driving large-scale digital transformation initiatives for Fortune 500 companies. Currently the CEO at NexTurn and previously held key leadership and innovation roles at Accenture, and Infosys, delivering complex AI solutions, data platforms, and cloud systems
Seamless End to End Approach
Our Four-Pillar AI Approach
Intelligent Architecture
Key Application Areas in Clinical Trials
Intelligent Patient Recruitment
AI-powered matching algorithms identify ideal candidates faster, reducing recruitment time by up to 40% while ensuring better protocol fit.
Trial Design Optimization
Machine learning models analyze historical trial data to streamline protocols, select optimal endpoints, and predict potential challenges before they occur.
Trial Matcher and Data Scriber
An AI-powered tool that matches oncology patients to clinical trials based on real-time clinical and biomarker data.
Optimized Risk-Based Monitoring
Proactively identifies and prioritizes critical risks in clinical trials, enhancing data quality and patient safety.
Real-Time Performance Tracking and Data Management
Continuous data monitoring identifies trends, flags potential issues, and provides predictive insights to maintain trial integrity and data quality.
Automated Study And Regulatory Document Generation
Generative AI accelerates study related and regulatory document generation minimizing cost while ensuring compliance, reducing documentation time by up to 75%.
Intelligent Data Coding and Mapping to enable Data Integration
Automates the standardization of clinical data, enabling seamless integration and faster, compliant regulatory submissions.